Bio-medicus centrifugal ventricular support for postcardiotomy cardiac failure: A review of 129 cases

doi:10.1016/0003-4975(95)01025-4

The Annals of Thoracic Surgery

Volume 61, Issue 1, January 1996, Pages 291-295

https://doi.org/10.1016/0003-4975(95)01025-4 Get rights and content

Background.

Bio-Medicus centrifugal ventricular support has been used widely for postcardiotomy cardiac failure. The purpose of this study was to review a large series of support patients examining complications and outcomes.

Methods.

One hundred twenty-nine patients undergoing cardiac operations at The Methodist Hospital in Houston, Texas, were placed on Bio-Medicus centrifugal ventricular support for postcardiotomy cardiac failure; 102 were male and 27 were female with a mean age of 61.6 years. These patients were selected for ventricular support based solely on failure to be weaned from cardiopulmonary bypass or progressive postcardiotomy cardiac failure shortly after arrival in the intensive care unit.

Results.

These patients experienced numerous complications including coagulopathy, renal insufficiency or failure, sepsis, neurologic deficits, ventricular failure, arrhythmias, and death; 56.3% of patients were weaned from mechanical support and 21.0% were discharged alive. Causes of death included ventricular failure (62.4%), arrhythmias (12.9%), triage (6.9%), perioperative myocardial infarction or cardiac arrest (5.0%), coagulopathy (4.0%), sepsis syndrome (4.0%), cardiac graft failure (3.0%), and device related (1.0%). The one device-related death was a venous cannula dislodgment in the intensive care unit with subsequent exsanguination. Device-related complications were seen in only 1.6% of patients.

Conclusions.

Bio-Medicus centrifugal ventricular support can be implemented rapidly and relatively easily. There are few device-related complications and the cost is relatively inexpensive compared with other assist systems. This series demonstrates that a substantial number of patients who experience reversible postcardiotomy myocardial injury will benefit from temporary centrifugal ventricular support.

References (12)

NoonGP
Bio-Medicus ventricular assistance
Ann Thorac Surg
(1991)
SekelaME et al.
Comparison of hemodynamics and ejection fraction during left heart bypass
Ann Thorac Surg
(1991)
PaeWE
Ventricular assist devices and total artificial hearts: a combined registry experience
Ann Thorac Surg
(1993)
NormanJL et al.
Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping
J Thorac Cardiovasc Surg
(1977)
DowningTP et al.
Use of the intra-aortic balloon pump after valve replacement
J Thorac Cardiovasc Surg
(1986)
PenningtonDG et al.
Intra-aortic balloon pumping cardiac surgical patients: a nine year experience
Ann Thorac Surg
(1983)

There are more references available in the full text version of this article.

Cited by (50)

Successful extracorporeal membrane oxygenation for right heart failure after heart transplantation - 2 case reports and literature review
2013, Transplantation Proceedings
After heart transplantation (HT), transient right heart failure (RHF) is common. If it does not improve with appropriate medical therapy, we must consider mechanical support. Recently, extracorporeal membrane oxygenation (ECMO) has shown better results than a right ventricular assist device or retransplantation. Two HT patients with hypertrophic cardiomyopathy had cold ischemic times beyond >240 minutes. After HT, their right heart function worsened and was unresponsive to medical therapy. After our application of ECMO, weaning was successful and the patients were discharged without complication. Early application of ECMO for RHF after HT is a good option.
Clinical practice guide for the management of low cardiac output syndrome in the postoperative period of heart surgery
2012, Medicina Intensiva
El síndrome de bajo gasto cardiaco es una potencial complicación de los pacientes intervenidos de cirugía cardiaca, y asocia un aumento de la morbi-mortalidad. La presente guía pretende proporcionar recomendaciones para el manejo de estos pacientes, en el postoperatorio inmediato, ingresados en UCI. Las recomendaciones se han agrupado en diferentes apartados, tratando de dar respuesta desde los conceptos más básicos como es la definición, a los diferentes apartados de monitorización básica y avanzada y terminando con el complejo manejo de este síndrome. Se propone un algoritmo de manejo inicial, asi como otros de fracaso ventricular predominantemente izquierdo o derecho. La mayor parte de las recomendaciones están basadas en el consenso de expertos, debido a la falta de estudios clínicos aleatorizados, de adecuado diseño y tamaño muestral en este grupo de pacientes. La calidad de la evidencia y la fuerza de las recomendaciones se realizó siguiendo la metodología GRADE. La guía se presenta como una lista de recomendaciones (y nivel de evidencia de cada recomendación) para cada pregunta del tema seleccionado. A continuación, en cada pregunta, se procede a la justificación de las recomendaciones.
The low cardiac output syndrome is a potential complication in cardiac surgery patients and associated with increased morbidity and mortality. This guide is to provide recommendations for the management of these patients, immediately after surgery, admitted to the ICU. The recommendations are grouped into different sections, trying to answer from the most basic concepts such as the definition to the different sections of basic and advanced monitoring and ending with the complex management of this syndrome. We propose an algorithm for initial management, as well as two other for ventricular failure (predominantly left or right). Most of the recommendations are based on expert consensus because of the lack of randomized trials of adequate design and sample size in this group of patients. The quality of evidence and strength of the recommendations were made following the GRADE methodology. The guide is presented as a list of recommendations (and level of evidence for each recommendation) for each question on the selected topic. Then for each question, we proceed to the justification of the recommendations.
Cardiac Transplantation and Circulatory Support Devices
2007, Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease
Cardiac transplantation and circulatory support devices
2006, Cardiovascular Therapeutics - A Companion to Braunwald's Heart Disease: Expert Consult - Online and Print
Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart Transplantation
2004, Annals of Thoracic Surgery
Citation Excerpt :
Noon and associates [12] reported the use of RVAD in 17 patients with cardiac allograft failure after heart transplantation with a mortality of 85%. The same group published the use of RVAD in 7 patients with a hospital mortality of 100% [13]. Minev and colleagues [14] published the results of implanting a Bio-Medicus centrifugal pump for refractory RVF with an overall mortality of 84%.
Acute right ventricular failure after heart transplantation is a life-threatening condition, and sometimes the use of mechanical circulatory support is inevitable. The aim of this retrospective study was to investigate the effectiveness of two different mechanical circulatory support systems for this indication.
From 1984 to 2003, 28 heart transplant recipients exhibited right ventricular failure resistant to drug therapy. Right ventricular assist device (n = 15) or extracorporeal membrane oxygenation (n = 13) was implanted to support the failing heart.
Overall in-hospital survival was 43%. In the right ventricular assist device group, only 2 patients (13%) could be weaned from mechanical circulatory support compared with 10 patients (77%) in the extracorporeal membrane oxygenation group (p = 0.001). Retransplantation was necessary in 6 patients in the right ventricular assist device group and in 1 patient in the extracorporeal membrane oxygenation group (p = 0.049). There was no difference in patient survival between groups, but graft survival was significantly better in the extracorporeal membrane oxygenation group (p = 0.005).
In view of these results, extracorporeal membrane oxygenation seems to be the better option as mechanical circulatory support for right ventricular failure in heart transplantation.
Care of the adult cardiac surgery patient: Part I
2004, Current Problems in Surgery

View all citing articles on Scopus

View full text

Bio-medicus centrifugal ventricular support for postcardiotomy cardiac failure: A review of 129 cases

Background.

Methods.

Results.

Conclusions.

Ann Thorac Surg

Ann Thorac Surg

Ann Thorac Surg

J Thorac Cardiovasc Surg

J Thorac Cardiovasc Surg

Ann Thorac Surg